Success Metrics

Clinical Success Rate
87.5%

Based on 35 completed trials

Completion Rate
88%(35/40)
Active Trials
5(8%)
Results Posted
11%(4 trials)
Terminated
5(8%)

Phase Distribution

Ph phase_2
7
11%
Ph phase_3
7
11%
Ph phase_1
1
2%
Ph not_applicable
32
52%
Ph phase_4
11
18%
Ph early_phase_1
3
5%

Phase Distribution

4

Early Stage

7

Mid Stage

18

Late Stage

Phase Distribution61 total trials
Early Phase 1First-in-human
3(4.9%)
Phase 1Safety & dosage
1(1.6%)
Phase 2Efficacy & side effects
7(11.5%)
Phase 3Large-scale testing
7(11.5%)
Phase 4Post-market surveillance
11(18.0%)
N/ANon-phased studies
32(52.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.4%

35 of 41 finished

Non-Completion Rate

14.6%

6 ended early

Currently Active

5

trials recruiting

Total Trials

61

all time

Status Distribution
Active(8)
Completed(35)
Terminated(6)
Other(12)

Detailed Status

Completed35
unknown12
Terminated5
Recruiting4
Not yet recruiting3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
61
Active
5
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (4.9%)
Phase 11 (1.6%)
Phase 27 (11.5%)
Phase 37 (11.5%)
Phase 411 (18.0%)
N/A32 (52.5%)

Trials by Status

withdrawn12%
not_yet_recruiting35%
terminated58%
unknown1220%
active_not_recruiting12%
completed3557%
recruiting47%

Recent Activity

Clinical Trials (61)

Showing 20 of 61 trialsScroll for more
NCT07364331Not Applicable

Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)

Recruiting
NCT07365553Not Applicable

Omega-3, Autism Spectrum Disorder (ASD)

Recruiting
NCT07348562Not Applicable

Omega-3, Inflammation in ADHD With AI

Completed
NCT06055894Not Applicable

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Recruiting
NCT06538324Not Applicable

Response to an Intervention With Omega-3 (RIO - Study)

Completed
NCT07136519Phase 2

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

Not Yet Recruiting
NCT07134140Not Applicable

Omega-3 Fatty Acids in Muscle Function and Health

Not Yet Recruiting
NCT06015971Not Applicable

Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer

Recruiting
NCT06494566Early Phase 1

Omega-3 Supplementation After Surgical Treatment of Obesity

Completed
NCT06328426Not Applicable

Vitamin D With Omega-3 or Metformin in Osteoarthritis

Not Yet Recruiting
NCT05116878Not Applicable

Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma

Terminated
NCT05990712Phase 4

The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers

Unknown
NCT05945693Not Applicable

Omega-3 and Exercise in Rheumatoid Arthritis People

Unknown
NCT05941754Not Applicable

A Clinical Study of Omega-3 on Depression and Cognition

Unknown
NCT05847608Not Applicable

Omega-3 Treatment for Concussion in Adolescents

Unknown
NCT05711810Phase 4

Medicine-induced Cardiac Hemodialysis on COVID-19

Completed
NCT04586933Not Applicable

Nutrition in Rheumatic Diseases

Unknown
NCT03598413Not Applicable

PeRioperative Omega Three and the Effect on ImmuNity

Completed
NCT04279951Not Applicable

Alpha and Omega of Lifestyle Therapy

Active Not Recruiting
NCT01235130Phase 3

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
61